{"transactions":[{"id":1932059,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114852,"kind":"person","name":"Royer Scott E.","position":1,"cik":"0001747756","reported_name":"Royer Scott E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-03T16:32:43.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date."}],"balance_after":32000,"derivative":{"exercise_price":0.3995,"expiration_date":"2033-03-30","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001062993-23-008321","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323008321/form4.xml","form_type":"4"}},{"id":2307638,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114852,"kind":"person","name":"Royer Scott E.","position":1,"cik":"0001747756","reported_name":"Royer Scott E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T16:32:04.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date."}],"balance_after":16000,"derivative":{"exercise_price":1.29,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001062993-22-009444","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322009444/form4.xml","form_type":"4"}},{"id":2760703,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114852,"kind":"person","name":"Royer Scott E.","position":1,"cik":"0001747756","reported_name":"Royer Scott E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T16:28:13.000Z","date":"2021-04-02","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date."}],"balance_after":6000,"derivative":{"exercise_price":2.93,"expiration_date":"2031-04-02","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000891839-21-000101","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183921000101/edgar.xml","form_type":"4"}},{"id":3038850,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114852,"kind":"person","name":"Royer Scott E.","position":1,"cik":"0001747756","reported_name":"Royer Scott E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-03T16:23:47.000Z","date":"2020-09-03","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date."}],"balance_after":1500,"derivative":{"exercise_price":3.9,"expiration_date":"2029-03-14","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0000891839-20-000256","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183920000256/edgar.xml","form_type":"4"}},{"id":3038849,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114852,"kind":"person","name":"Royer Scott E.","position":1,"cik":"0001747756","reported_name":"Royer Scott E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-09-03T16:23:47.000Z","date":"2020-09-03","kind":"exercise","acquired":true,"shares":500,"price":3.9,"value":1950.0,"ownership":{"direct":true},"balance_after":4499,"source":{"system":"sec-edgar","filing":"0000891839-20-000256","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183920000256/edgar.xml","form_type":"4"}},{"id":3245963,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114852,"kind":"person","name":"Royer Scott E.","position":1,"cik":"0001747756","reported_name":"Royer Scott E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-26T16:23:05.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date."}],"balance_after":2000,"derivative":{"exercise_price":6.07,"expiration_date":"2030-02-24","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000891839-20-000050","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183920000050/edgar.xml","form_type":"4"}},{"id":3586060,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114852,"kind":"person","name":"Royer Scott E.","position":1,"cik":"0001747756","reported_name":"Royer Scott E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-19T16:49:02.000Z","date":"2019-03-15","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date."}],"balance_after":2000,"derivative":{"exercise_price":3.9,"expiration_date":"2029-03-14","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000891839-19-000051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183919000051/edgar.xml","form_type":"4"}},{"id":3667824,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114852,"kind":"person","name":"Royer Scott E.","position":1,"cik":"0001747756","reported_name":"Royer Scott E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-02-08T16:34:26.000Z","date":"2019-02-07","kind":"purchase","acquired":true,"shares":1725,"price":5.05,"value":8711.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.75 to $5.17 per share, inclusive. Mr. Royer undertakes to provide to Vaccinex, Inc., any securityholder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":3999,"source":{"system":"sec-edgar","filing":"0000891839-19-000033","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183919000033/edgar.xml","form_type":"4"}},{"id":3667823,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114852,"kind":"person","name":"Royer Scott E.","position":1,"cik":"0001747756","reported_name":"Royer Scott E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-02-08T16:34:26.000Z","date":"2019-02-06","kind":"purchase","acquired":true,"shares":275,"price":4.57,"value":1256.75,"ownership":{"direct":true},"balance_after":2274,"source":{"system":"sec-edgar","filing":"0000891839-19-000033","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183919000033/edgar.xml","form_type":"4"}},{"id":3692702,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114852,"kind":"person","name":"Royer Scott E.","position":1,"cik":"0001747756","reported_name":"Royer Scott E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-01-17T16:29:27.000Z","date":"2019-01-15","kind":"purchase","acquired":true,"shares":1688,"price":4.31,"value":7275.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.30 to $4.3928. Mr. Royer undertakes to provide to Vaccinex, Inc., any securityholder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":1999,"source":{"system":"sec-edgar","filing":"0000891839-19-000022","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183919000022/edgar.xml","form_type":"4"}},{"id":3715850,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114852,"kind":"person","name":"Royer Scott E.","position":1,"cik":"0001747756","reported_name":"Royer Scott E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-12-31T16:10:45.000Z","date":"2018-12-27","kind":"purchase","acquired":true,"shares":311,"price":4.15,"value":1290.65,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.10 to $4.20. The reporting person undertakes to provide to Vaccinex, Inc., any securityholder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number or shares purchased at each separate price."}],"balance_after":311,"source":{"system":"sec-edgar","filing":"0000891839-18-000122","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183918000122/edgar.xml","form_type":"4"}}]}